Webinar: The Importance of Data Integrity for Endotoxin Testing

Date: 09 May 2017 Location: Online event City: Online event Country: Online event

Data integrity and its practical maintenance are crucial to the quality of healthcare products and the safety of patients.

 

Watch this 60-minute free webinar for a comprehensive overview on data integrity and how it relates to endotoxin testing. During this webinar we do not only discuss why data integrity is important, but also take a look at the issues that may occur and the tools you can use to address them.

                               

 

 Register to watch the webinar

   

 

 


Webinar Speaker Robert Porzio, Lonza 

Robert Porzio

Product Manager for
Endotoxin Detection, Lonza

View biography

Robert Porzio is a Product Manager for Endotoxin Detection at Lonza, with a primary focus on instrumentation and software.

 

Robert has 20 years of endotoxin experience, including his work at Charles River and Associates of Cape Cod in production, marketing and sales. During his time at Associates of Cape Cod, Robert also gained European experience, as he worked three years in Germany performing marketing and sales for Pyroquant Diagnostik GmBH, the German ACC subsidiary. Prior to joining Lonza, Robert established his own endotoxin testing distribution company, where he sold the Hyglos rFC and Wako endotoxin reagents, amongst others.

 

His past professional experience in the field of Microbiology at Johnson & Johnson has been a huge benefit in understanding the criticality of data integrity in the laboratory and addressing data integrity in endotoxin testing requirements.

 

Robert is a graduate of the College of Charleston and holds a degree in Biology and Psychology.

 

Topics include:

  • Data integrity basics and corporate governance from the FDA
  • Introduction to Kinetic Testing with emphasis focused on observations of subjective test methods
  • Data integrity components through the WinKQCL™ Endotoxin Detection & Analysis Software and how it helps comply with the FDA’s data integrity guidance
  • Establishing a risk-based approach to your review processCreating a FMEA (Failure Modes and Effects Analysis)
  • Document assay process flow from sample preparation to review and release of results

   

 

 

To view the schedule of upcoming webinars, please go to www.lonza.com/qcwebinars. To benefit from our previously shared know-how, please visit our webinar archive.

 

For further information please visit our endotoxin detection page.

Bg